Cutting edge: B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice

C Hulbert, B Riseili, M Rojas… - The Journal of …, 2001 - journals.aai.org
Type I diabetes mellitus (TIDM) is an autoimmune disorder characterized by T cell-mediated
destruction of insulin-producing β cells in the pancreas. In the nonobese diabetic (NOD) …
被引用次数：180 相关文章

Cutting edge: B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice

C Hulbert, B Riseili, M Rojas… - Journal of …, 2001 - ohiostate.elsevierpure.com
Type I diabetes mellitus (TIDM) is an autoimmune disorder characterized by T cell-mediated
destruction of insulin-producing β cells in the pancreas. In the nonobese diabetic (NOD) …

Cutting Edge: B Cell Specificity Contributes to the Outcome of Diabetes in Nonobese Diabetic Mice

C Hulbert, B Riseili, M Rojas… - The Journal of …, 2001 - journals.aai.org
Type I diabetes mellitus (TIDM) is an autoimmune disorder characterized by T cell-mediated
destruction of insulin-producing β cells in the pancreas. In the nonobese diabetic (NOD) …

B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice.

C Hulbert, B Riseili, M Rojas… - Journal of Immunology …, 2001 - europepmc.org
Type I diabetes mellitus (TIDM) is an autoimmune disorder characterized by T cell-mediated
destruction of insulin-producing beta cells in the pancreas. In the nonobese diabetic (NOD) …

B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice

C Hulbert, B Riseili, M Rojas… - Journal of immunology …, 2001 - pubmed.ncbi.nlm.nih.gov
Type I diabetes mellitus (TIDM) is an autoimmune disorder characterized by T cell-mediated
destruction of insulin-producing beta cells in the pancreas. In the nonobese diabetic (NOD) …